Recent Press Releases

New Clinical Study of Flublok® Influenza Vaccine Shows That Groundbreaking Flublok Is More Effective Than the Traditional Flu Shot

MERIDEN, Conn., June 25, 2015 /PRNewswire/ -- Protein Sciences Corporation announced today topline data showing that Flublok® Quadrivalent – the quadrivalent version of FDA-approved...

Cancer Vaccines Market Growing at 27% CAGR to 2019

DALLAS, June 25, 2015 /NEWS.GNOM.ES/ — The Global Cancer Vaccines Market 2015-2019 report says use of vaccines in combination with other therapies is propelling the growth of cancer vaccines...

Cleveland BioLabs Enters Into Private Placement Agreement With Strategic Investor for $25 Million Equity Financing

BUFFALO, NY--(Marketwired - Jun 25, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has entered into a securities purchase agreement with David Davidovich, a venture capital...

Candidate vaccine gears up for clinical trials

Candidate vaccine gears up for clinical trials München, 06/22/2015 LMU researchers have demonstrated, in a preclinical setting, the protective effect of a candidate vaccine directed against the...

US CDC committee recommends physicians make individual decisions on the use of meningococcal group B vaccines

GSK's BEXSERO® included in Category B recommendation by ACIP GlaxoSmithKline (LSE: GSK) announced today that the U.S. Centers for Disease Control (CDC) Advisory Committee on Immunization...

Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (PFE) today announced that it has entered into an agreement with GlaxoSmithKline (GSK) to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and...

EpiVax Reports $5.2 Million for New Q Fever Vaccine Means There is Hope for Vaccines On Demand

PROVIDENCE, Rhode Island, June 11, 2015 /PRNewswire/ -- EpiVax reports today that the Defense Threat Reduction Agency (DTRA) is investing $5.2 Million for the development of a new type of vaccine...

Genticel's GTL001 phase 1 clinical study of HPV therapeutic vaccine granted FDA clearance

Genticel (Euronext Paris & Brussels: FR00011790542 – GTCL), a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus...

Vaccine Specialist AFFiRiS AG Successfully Completes Financing Round

VIENNA, June 16, 2015 /PRNewswire/ -- - € 10m additional capital raised - Supervisory Board appoints Oliver Siegel as Chief Executive Officer - Prof. Dr. Christoph Huber elected to Supervisory...

Sanofi Pasteur MSD: GARDASIL9: New HPV Vaccine Approved in the European Union

LYON, France, June 17, 2015 /PRNewswire/ -- Sanofi Pasteur MSD announced today that the European Commission has granted marketing authorization for GARDASIL 9. GARDASIL 9 is a 9-valent HPV vaccine...

Hualan is the First Influenza Vaccine Manufacturer in China Getting WHO Prequalification Approval

In June 10th, the influenza vaccine (split virion, inactivated) of Hualan Bio passes the world health organization (WHO) pre-qualification and is taken into UN purchase plan. This is the first time...

Cellular Biomedicine Group Enters Into Definitive Agreement to Acquire CD40LGVAX Vaccine and Related Technologies and Know-How Which Will be Used in a Pending PD-1 Combination Clinical Trial in the U.S. for Non-Small Cell Lung Cancer (NSCLC)

SHANGHAI, China and PALO ALTO, Calif., June 9, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the...

Massachusetts General Hospital launches phase II trial of BCG vaccine to reverse type 1 diabetes

A phase II clinical trial testing the ability of the generic vaccine bacillus Calmette-Guérin (BCG) to reverse advanced type 1 diabetes has received approval from the U.S. Food and Drug...

New way to tackle vaccine hesitancy tested, found wanting

SEATTLE--Group Health Research Institute conducted the first randomized trial to test an intervention aimed at improving hesitancy about early childhood vaccines by working directly with doctors. Vax...

Soligenix Announces Publication of Successful Application of its Heat Stabilization Technology to a Human Papillomavirus Vaccine

PRINCETON, N.J., June 2, 2015 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in...

Anti-Ebola MVA Vaccine Produced on ProBioGen's Avian AGE1.CR® Cell Line Platform in Clinical Trials

"Production of the first ever batch of MVA for a clinical trial using a cell line" Berlin, Germany, June 2, 2015 / B3C newswire / -- Complex biologics development and manufacturing...

FDA Grants 12 Year Exclusivity to Flublok® Influenza Vaccine

MERIDEN, Conn., June 3, 2015 /PRNewswire/ -- Protein Sciences Corporation announced that in a rare move, the FDA is granting exclusivity to Flublok for a period of 12 years. Flublok is the first...

Shingles Vaccine Associated with Reduced Risk of Long-Term Pain Among Patients

PASADENA, Calif., June 2, 2015 /PRNewswire/ -- People who received a vaccination for shingles (also known as herpes zoster) but still contracted shingles had a lower risk of developing post-herpetic...

VaxInnate Advances Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, into Phase 2 Study

Cranbury, NJ, June 3, 2015 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a breakthrough vaccine technology platform, today announced the initiation of a double-blind,...

Takeda Announces Consolidation of U.S. Vaccine Sites in Boston/Cambridge Area

DEERFIELD, Ill. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited ("Takeda") will consolidate its Vaccine Business Unit (VBU) operations by establishing global and regional...